Csenge Advisory Group’s Predictive Oncology POAI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,000
| Closed | -$24.6K | – | 729 |
|
|
2024
Q4 | $24.6K | Buy |
30,000
+17,000
| +131% | +$13.9K | ﹤0.01% | 692 |
|
|
2024
Q3 | $7.99K | Buy |
+13,000
| New | +$7.99K | ﹤0.01% | 703 |
|
|
2023
Q2 | – | Sell |
-2,750
| Closed | -$18K | – | 688 |
|
|
2023
Q1 | $18K | Buy |
2,750
+1,250
| +83% | +$8.17K | ﹤0.01% | 591 |
|
|
2022
Q4 | $9.2K | Sell |
1,500
-475
| -24% | -$2.91K | ﹤0.01% | 596 |
|
|
2022
Q3 | $14K | Buy |
1,975
+725
| +58% | +$5.14K | ﹤0.01% | 607 |
|
|
2022
Q2 | $10K | Buy |
1,250
+125
| +11% | +$1K | ﹤0.01% | 567 |
|
|
2022
Q1 | $22K | Hold |
1,125
| – | – | ﹤0.01% | 623 |
|
|
2021
Q4 | $29K | Hold |
1,125
| – | – | ﹤0.01% | 544 |
|
|
2021
Q3 | $33K | Hold |
1,125
| – | – | ﹤0.01% | 570 |
|
|
2021
Q2 | $29K | Sell |
1,125
-100
| -8% | -$2.58K | ﹤0.01% | 547 |
|
|
2021
Q1 | $37K | Buy |
1,225
+200
| +20% | +$6.04K | ﹤0.01% | 488 |
|
|
2020
Q4 | $15K | Hold |
1,025
| – | – | ﹤0.01% | 427 |
|
|
2020
Q3 | $16K | Buy |
1,025
+150
| +17% | +$2.34K | ﹤0.01% | 389 |
|
|
2020
Q2 | $29K | Buy |
+875
| New | +$29K | ﹤0.01% | 370 |
|
|
2018
Q4 | – | Sell |
-3
| Closed | – | – | 1143 |
|
|
2018
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1475 |
|